Quantinno Capital Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.09M Buy
70,880
+8,170
+13% +$122K ﹤0.01% 2728
2026
Q2
$816K Buy
62,710
+19,171
+44% +$218K ﹤0.01% 2712
2026
Q1
$495K Buy
43,539
+5,675
+15% +$61.5K ﹤0.01% 2716
2025
Q4
$486K Buy
37,864
+8,535
+29% +$105K ﹤0.01% 2462
2025
Q3
$328K Buy
29,329
+9,248
+46% +$89.3K ﹤0.01% 2387
2025
Q2
$199K Buy
+20,081
New +$197K ﹤0.01% 2366

Other funds holding ANGO

Quantinno Capital Management's ANGO Position: Q3 2026 in Review

Quantinno Capital Management increased its AngioDynamics (ANGO) stake by 13% in Q3 2026, buying an estimated $122K and bringing the position to 70,880 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2728.

Quantinno Capital Management first reported a position in ANGO in Q2 2025 and has held it in 6 quarters since. 122 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

  • Quantinno Capital Management held 70,880 shares of AngioDynamics worth $1.09M as of Q3 2026.
  • Quantinno Capital Management bought 8,170 AngioDynamics shares in Q3 2026, an estimated $122K.
  • AngioDynamics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2728 holding.
  • Quantinno Capital Management first reported a position in AngioDynamics in Q2 2025 and has held it in 6 quarters since.
  • 122 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.